検索結果 - Vaknin-Dembinsky, Adi
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis 著者: Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Levin, Netta, Shifrin, Alla, Rozenberg, Ayal, Vaknin-Dembinsky, Adi
出版事項 2022テキスト -
10
-
11
-
12
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells 著者: Zveik, Omri, Fainstein, Nina, Rechtman, Ariel, Haham, Nitzan, Ganz, Tal, Lavon, Iris, Brill, Livnat, Vaknin‐Dembinsky, Adi
出版事項 2022テキスト -
13
-
14
-
15
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107 著者: Mizrachi, Tehila, Marsha, Oshrit, Brusin, Karen, Ben-David, Yael, Thakur, Ganesh A., Vaknin-Dembinsky, Adi, Treinin, Millet, Brenner, Talma
出版事項 2021テキスト -
16
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab 著者: Brill, Livnat, Raposo, Catarina, Rechtman, Ariel, Zveik, Omri, Levin, Netta, Oiknine‐Djian, Esther, Wolf, Dana G., Vaknin‐Dembinsky, Adi
出版事項 2022テキスト -
17
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine() 著者: Brill, Livnat, Rechtman, Ariel, Shifrin, Alla, Rozenberg, Ayal, Afanasiev, Svetlana, Zveik, Omri, Haham, Nitzan, Levin, Neta, Vaknin-Dembinsky, Adi
出版事項 2022テキスト -
18
-
19
-
20
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab 著者: Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Oiknine-Djian, Esther, Wolf, Dana G., Levin, Netta, Raposo, Catarina, Vaknin-Dembinsky, Adi
出版事項 2021テキスト